Showing results (61-70 of 101) with videos related to

Sort By:
Pageof 11
Thrombosis and Haemostasis|December 4, 2015
Increased inhibitor incidence in severe haemophilia A since 1990 attributable to more low titre inhibitorsH Marijke van den Berg, S Mojtaba Hashemi, Kathelijn Fischer, et al.
Thrombosis and Haemostasis|February 16, 2018
Recombinant FXIII (rFXIII-A2) Prophylaxis Prevents Bleeding and Allows for Surgery in Patients with Congenital FXIII A-Subunit DeficiencyManuel Carcao, Carmen Altisent, Giancarlo Castaman, et al.
Research and Practice in Thrombosis and Haemostasis|July 12, 2019
Fixed doses of N8-GP prophylaxis maintain moderate-to-mild factor VIII levels in the majority of patients with severe hemophilia APratima Chowdary, Manuel Carcao, Pål A Holme, et al.
Blood|April 14, 2022
First study of extended half-life rFVIIIFc in previously untreated patients with hemophilia A: PUPs A-LONG final resultsChristoph Königs, Margareth C Ozelo, Amy Dunn, et al.
Journal of Thrombosis and Haemostasis : JTH|July 24, 2025
Predictors of immune tolerance induction success in 231 children with severe hemophilia A with high-titer inhibitors - lessons learned from the PedNet prospective cohort studyManuel Carcao, Christoph Königs, Nadine G Andersson, et al.
Thrombosis and Haemostasis|February 27, 2016
Impact of aerobic exercise on haemostatic indices in paediatric patients with haemophiliaRiten Kumar, Vanessa Bouskill, Jane E Schneiderman, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 23, 2021
Factor product utilization and health outcomes in patients with haemophilia A and B on extended half-life concentrates: A Canadian observational study of real-world outcomesHaowei Linda Sun, Ming Yang, Man-Chiu Poon, et al.
Research and Practice in Thrombosis and Haemostasis|March 9, 2023
Determinants of successful immune tolerance induction in hemophilia A: systematic review and meta-analysisIlja Oomen, Ricardo M Camelo, Suely Meireles Rezende, et al.
Research and Practice in Thrombosis and Haemostasis|October 20, 2021
The impact of extended half-life factor concentrates on patient reported health outcome measures in persons with hemophilia A and hemophilia BHaowei Linda Sun, Ming Yang, Man-Chiu Poon, et al.
Research and Practice in Thrombosis and Haemostasis|April 19, 2021
Updating the Canadian Hemophilia Outcomes-Kids' Life Assessment Tool (CHO-KLAT) in the era of extended half-life clotting factor concentratesVictoria E Price, Saunya Dover, Victor S Blanchette, et al.
Pageof 11